ArticleScientific reports2025
Vascular risk factor variability and cognitive impairment in older adults a community-based retrospective study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Semaglutide in cognitive dysfunction: neuroprotective potential, clinical trial limitations, and a prevention-focused framework.Frontiers in aging neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The association between vascular risk factors and cognitive performance has been a topic of considerable interest. Nevertheless, the connection between vascular risk factors and cognitive impairment in the elderly population continues to be ambiguous. From January to April 2022, participants aged 65 years and older were recruited in the community. A retrospective review of data was conducted, those who underwent at least three discrete health assessments between 2018 and 2021 were included in the study. Cognitive function was evaluated in 2022 by Mini-mental state examination (MMSE) in the Chinese version. Logistic regression was employed to explore the association of various vascular risk factors (body mass index [BMI], exercise frequency, smoking status, drinking status, systolic blood pressure [SBP], diastolic blood pressure [DBP], total cholesterol [TC], triglycerides [TG], low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], fasting plasma glucose [FPG]) and their variability (intra-individual variability across at least four measurement occasions) with cognitive impairment. Odd ratios (OR) and 95% confidence intervals (CI) were reported. This study included 1,487 participants. Findings indicated that physical activity and alcohol drinking were inversely related to cognitive impairment risk. Moreover, average DBP, TC, LDL-C, and FPG at follow-up were positively correlated with cognitive impairment risk, while HDL-C was linked to a reduced risk. Variability assessments reflected high variability in DBP, TG, TG, LDL-C, HDL-C, and FPG associated with cognitive impairment development. In this research, we conducted a thorough examination of the relationship between four primary vascular risk factors (11 indicators) and the likelihood of cognitive impairment. Our results indicate that various vascular risk factors are associated with the onset of cognitive impairment in the elderly population. These findings may contribute to the formulation of future guidelines aimed at mitigating the risk of cognitive impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.